NCT01332422View on ClinicalTrials.gov

Special Drug Use Investigation for ADOAIR Metered-dose Inhaler (Pediatric)

CompletedOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions

Asthma

Interventions

DRUG

Salmeterol and Fluticasone

Collection of safety data

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01332422 - Special Drug Use Investigation for ADOAIR Metered-dose Inhaler (Pediatric) | Biotech Hunter | Biotech Hunter